Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:50-58
Published online before print May 24, 2007, doi: 10.1161/CIRCRESAHA.106.145847
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
101/1/50    most recent
CIRCRESAHA.106.145847v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorovoy, M.
Right arrow Articles by Voyno-Yasenetskaya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorovoy, M.
Right arrow Articles by Voyno-Yasenetskaya, T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Pulmonary biology and circulation
Right arrowRelated Article
(Circulation Research. 2007;101:50.)
© 2007 American Heart Association, Inc.


Molecular Medicine

RhoGDI-1 Modulation of the Activity of Monomeric RhoGTPase RhoA Regulates Endothelial Barrier Function in Mouse Lungs

Matvey Gorovoy*, Radu Neamu*, Jiaxin Niu, Stephen Vogel, Dan Predescu, Jun Miyoshi, Yoshimi Takai, Vidisha Kini, Dolly Mehta, Asrar B. Malik, Tatyana Voyno-Yasenetskaya

From the Department of Pharmacology (M.G., R.N., J.N., S.V., D.P., V.K., D.M., A.B.M., T.V.-Y.), University of Illinois College of Medicine and Center for Lung and Vascular Biology, Chicago; the Department of Molecular Biology (J.M.), Osaka Medical Center for Cancer and Cardiovascular Diseases, and the Department of Molecular Biology and Biochemistry (Y.T.), Osaka University School of Medicine, Osaka, Japan.

Correspondence to Dr T. Voyno-Yasenetskaya, University of Illinois, Department of Pharmacology (MC 868), 835 S. Wolcott Ave, Chicago, IL 60612. E-mail tvy{at}uic.edu

Rho family GTPases have been implicated in the regulation of endothelial permeability via their actions on actin cytoskeletal organization and integrity of interendothelial junctions. In cell culture studies, activation of RhoA disrupts interendothelial junctions and increases endothelial permeability, whereas activation of Rac1 and Cdc42 enhances endothelial barrier function by promoting the formation of restrictive junctions. The primary regulators of Rho proteins, guanine nucleotide dissociation inhibitors (GDIs), form a complex with the GDP-bound form of the Rho family of monomeric G proteins, and thus may serve as a nodal point regulating the activation state of RhoGTPases. In the present study, we addressed the in vivo role of RhoGDI-1 in regulating pulmonary microvascular permeability using RhoGDI-1–/– mice. We observed that basal endothelial permeability in lungs of RhoGDI-1–/– mice was 2-fold greater than wild-type mice. This was the result of opening of interendothelial junctions in lung microvessels which are normally sealed. The activity of RhoA (but not of Rac1 or Cdc42) was significantly increased in RhoGDI-1–/– lungs as well as in cultured endothelial cells on downregulation of RhoGDI-1 with siRNA, consistent with RhoGDI-1–mediated modulation RhoA activity. Thus, RhoGDI-1 by repressing RhoA activity regulates lung microvessel endothelial barrier function in vivo. In this regard, therapies augmenting endothelial RhoGDI-1 function may be beneficial in reestablishing the endothelial barrier and lung fluid balance in lung inflammatory diseases such as acute respiratory distress syndrome.


Key Words: RhoGDI • Rho GTPase • endothelial permeability • lung perfusion


Related Article:

Endogenous RhoA Inhibitor Protects Endothelial Barrier
Geerten P. van Nieuw Amerongen and Victor W.M. van Hinsbergh
Circ. Res. 2007 101: 7-9. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Ramchandran, D. Mehta, S. M. Vogel, M. K. Mirza, P. Kouklis, and A. B. Malik
Critical role of Cdc42 in mediating endothelial barrier protection in vivo
Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L363 - L369.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. P. van Nieuw Amerongen and V. W.M. van Hinsbergh
Endogenous RhoA Inhibitor Protects Endothelial Barrier
Circ. Res., July 6, 2007; 101(1): 7 - 9.
[Full Text] [PDF]